SCHEMBL3143475

SCHEMBL3143475

O=C1Nc2cc(C(=O)O)ccc2/C1=C(/Nc1ccc(Br)cc1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.46
MEN1 O00255 8/20 0.41
KMT2A Q03164 8/20 0.41
TP53 P04637 3/20 0.41
CCNB2 O95067 2/20 0.40
CDK1 P06493 2/20 0.40
CCNB1 P14635 2/20 0.40
CCNB3 Q8WWL7 2/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
HSP90AA1 P07900 1/20 0.40
CCR6 P51684 1/20 0.40
EPHX1 P07099 1/20 0.40
CASP3 P42574 2/20 0.39
POLB P06746 1/20 0.39
RAB9A P51151 1/20 0.39
PDGFRB P09619 1/20 0.38
KIT P10721 1/20 0.38
FLT4 P35916 1/20 0.38
FLT3 P36888 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6770244 1.00 BACE1 (0.46) BACE1MEN1KMT2ATP53CCNB2
SCHEMBL20710161 0.93 BACE1 (0.46) BACE1MEN1KMT2ACASP3PDGFRB
SCHEMBL3156104 0.92 BACE1 (0.45) BACE1MEN1KMT2ATP53CCNB2
SCHEMBL6770828 0.92 BACE1 (0.45) BACE1MEN1KMT2ATP53CCNB2
SCHEMBL5270139 0.91 BACE1 (0.46) BACE1MEN1KMT2ATP53CASP3
SCHEMBL480759 0.89 KMT2A (0.43) BACE1MEN1KMT2ATP53POLB
SCHEMBL480757 0.89 KMT2A (0.43) BACE1MEN1KMT2ATP53POLB
SCHEMBL2570441 0.88 BACE1 (0.46) BACE1MEN1KMT2ATP53CASP3
SCHEMBL2570438 0.88 BACE1 (0.46) BACE1MEN1KMT2ATP53CASP3
SCHEMBL4500243 0.86 CES1 (0.43) BACE1MEN1KMT2ATP53CCNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2157081-A1 Indolinones substituted in six locations, their manufacture and their application as medicine Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2010-02-24 EP disclosed
US-6762180-B1 Substituted indolines which inhibit receptor tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2004-07-13 US disclosed
EP-1224170-A1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT Boehringer Ingelheim Pharma KG (DE) 2002-07-24 EP disclosed
WO-2001027081-A1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-04-19 WO disclosed